A PEPTIDE RECOGNIZED BY HUMAN CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS IS ENCODED BY AN INTRON SEQUENCE OF THE N-ACETYLGLUCOSAMINYLTRANSFERASE-V GENE
Y. Guilloux et al., A PEPTIDE RECOGNIZED BY HUMAN CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS IS ENCODED BY AN INTRON SEQUENCE OF THE N-ACETYLGLUCOSAMINYLTRANSFERASE-V GENE, The Journal of experimental medicine, 183(3), 1996, pp. 1173-1183
A cytolytic T lymphocyte (CTL) clone that lyses many HLA-A2 melanomas
was derived from a population of tumor-infiltrating lymphocytes of an
HLA-A2 melanoma patient. The gene coding for the antigen recognized by
this CTL was identified by transfection of a cDNA library. It is the
gene which has been reported to code for N-acetylglucosaminyltransfera
se V (GnT-V). Remarkably, the antigenic peptide recognized by the CTL
is encoded by a sequence located in an intron. In contrast to the full
y spliced GnT-V mRNA, which was found in a wide range of normal and tu
moral tissues, the mRNA containing the intron region coding for the an
tigen was not found at a significant level in normal tissues. This mRN
A was observed to be present in about 50% of melanomas. Our results su
ggest that a promoter located near the end of the relevant intron is a
ctivated in melanoma cells, resulting in the production of an mRNA cod
ing for the antigen.